WallStSmart

Cushman & Wakefield plc (CWK)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 14% more annual revenue ($11.77B vs $10.29B). WELL leads profitability with a 12.0% profit margin vs 0.9%. CWK appears more attractively valued with a PEG of 0.65. CWK earns a higher WallStSmart Score of 66/100 (B-).

CWK

Strong Buy

66

out of 100

Grade: B-

Growth: 6.7Profit: 5.0Value: 7.3Quality: 4.8
Piotroski: 3/9Altman Z: 1.56

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CWKUndervalued (+86.2%)

Margin of Safety

+86.2%

Fair Value

$101.46

Current Price

$13.95

$87.51 discount

UndervaluedFair: $101.46Overvalued
WELLSignificantly Overvalued (-58.0%)

Margin of Safety

-58.0%

Fair Value

$131.57

Current Price

$212.09

$80.52 premium

UndervaluedFair: $131.57Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CWK3 strengths · Avg: 8.7/10
EPS GrowthGrowth
57.1%10/10

Earnings expanding 57.1% YoY

PEG RatioValuation
0.658/10

Growing faster than its price suggests

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
162.6%10/10

Earnings expanding 162.6% YoY

Market CapQuality
$153.42B9/10

Large-cap with strong market position

Areas to Watch

CWK4 concerns · Avg: 3.5/10
P/E RatioValuation
36.7x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.564/10

Distress zone — elevated risk

Return on EquityProfitability
4.8%3/10

ROE of 4.8% — below average capital efficiency

Profit MarginProfitability
0.9%3/10

0.9% margin — thin

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.7%3/10

ROE of 3.7% — below average capital efficiency

PEG RatioValuation
3.662/10

Expensive relative to growth rate

P/E RatioValuation
105.5x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CWK

The strongest argument for CWK centers on EPS Growth, PEG Ratio, Price/Book. Revenue growth of 10.8% demonstrates continued momentum. PEG of 0.65 suggests the stock is reasonably priced for its growth.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : CWK

The primary concerns for CWK are P/E Ratio, Altman Z-Score, Return on Equity. Thin 0.9% margins leave little buffer for downturns.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.5x leaves little room for execution misses.

Key Dynamics to Monitor

CWK profiles as a value stock while WELL is a growth play — different risk/reward profiles.

CWK carries more volatility with a beta of 1.49 — expect wider price swings.

WELL is growing revenue faster at 38.3% — sustainability is the question.

WELL generates stronger free cash flow (647M), providing more financial flexibility.

Bottom Line

CWK scores higher overall (66/100 vs 57/100) and 10.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cushman & Wakefield plc

REAL ESTATE · REAL ESTATE SERVICES · USA

Cushman & Wakefield plc, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom and internationally. The company is headquartered in Chicago, Illinois.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?